News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–14
Matches
14
Sources here
6
Companies here
1
Search results Stored financial headlines

Active search

14 matching headlines

Ticker or company: AFJKMain company stories
Clear
Latest

TradingView Earnings

Aimei Health Technology Co., Ltd Revenue Breakdown – NASDAQ:AFJK

This article provides a revenue breakdown for Aimei Health Technology Co., Ltd (NASDAQ:AFJK) on TradingView. It offers an overview of the company's financials, including statements, statistics, dividends, earnings, and segments. The page also indicates that segment and regional performance data are available by source and by country.

Aimei Health Technology (AFJK) posts Q2 2026 loss and ends United Hydrogen deal

Aimei Health Technology (AFJK), a SPAC, reported a net loss of $37,704 for the six months ended June 30, 2026, primarily due to operational costs exceeding interest income from its trust account. The company also announced the termination of its previously agreed Business Combination …

AFJK main company
Sharemaestro market context Price below Trend Line 52 weeks +8.4% · Next-week setup positive 63.6% AFJK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BERKLEY W R CORP Exits Aimei Health Technology (AFJK) Entirely: A Case Study in SPAC Risk Management

BERKLEY W R CORP fully divested its position in Aimei Health Technology Co Ltd (AFJK), a SPAC, on June 30, 2026, selling all shares at $30.30. This exit proved timely as AFJK's stock subsequently plummeted by over 60% to $12.01, validating the firm's disciplined …

AFJK main company
Sharemaestro market context Price below Trend Line 52 weeks +8.4% · Next-week setup positive 63.6% AFJK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

AFJK 10-Q & SEC Filings

This article from Yahoo Finance reports on the latest SEC filings for AFJK, specifically its 10-Q periodic financial report. It lists associated exhibits such as EX-31.1, EX-31.2, EX-32.1, and EX-32.2. The article provides a direct link to the SEC Gov filing from June 16, …

AFJK main company
Sharemaestro market context Price below Trend Line 52 weeks +8.4% · Next-week setup positive 63.6% AFJK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aimei Health (AFJK): First Trust entities disclose 20%+ beneficial ownership

First Trust entities, including First Trust Merger Arbitrage Fund (VARBX), First Trust Capital Management L.P. (FTCM), First Trust Capital Solutions L.P. (FTCS), and FTCS Sub GP LLC (Sub GP), have disclosed significant beneficial ownership in Aimei Health Technology Co., Ltd. (AFJK). As of April …

AFJK main company
Sharemaestro market context Price below Trend Line 52 weeks +8.4% · Next-week setup positive 63.6% AFJK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aimei Health Technology Co., Ltd Revenue Breakdown – BOATS:AFJKU

This article provides a revenue breakdown for Aimei Health Technology Co., Ltd (AFJKU) on the TradingView platform. It highlights the company's financial overview, statements, statistics, dividends, earnings, and segmentation by source and country. The page is primarily a financial data portal, offering various tools …

AFJK main company
Sharemaestro market context Price below Trend Line 52 weeks +8.4% · Next-week setup positive 63.6% AFJK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aimei Health issues USD 34,331 interest-free promissory note to Aimei Health Ltd to fund trust extension payment

Aimei Health Technology has issued an unsecured, non-interest-bearing promissory note for $34,330.96 to Aimei Health Ltd to fund a one-month extension for its business-combination deadline. The principal becomes due upon completion of a business combination with United Hydrogen, and the payee has the option …

AFJK main company
Sharemaestro market context Price below Trend Line 52 weeks +8.4% · Next-week setup positive 63.6% AFJK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

W. R. Berkley (AFJK) files Schedule 13G/A showing no Aimei Health ownership

W. R. Berkley Corporation filed an amended Schedule 13G/A, disclosing that it beneficially owns 0 shares of Aimei Health Technology Co., Ltd (AFJK), representing 0.0% of the class. This filing indicates no sole or shared voting or dispositive power over any AFJK shares. The …

AFJK main company
Sharemaestro market context Price below Trend Line 52 weeks +8.4% · Next-week setup positive 63.6% AFJK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aimei Health Technology Co., Ltd Revenue Breakdown – BOATS:AFJK

This page from TradingView provides financial information for Aimei Health Technology Co., Ltd (AFJK) on the Blue Ocean Alternative Trade System. The content primarily consists of navigation and boilerplate text, with minimal actual financial data for the company. It outlines categories for viewing an …

AFJK main company
Sharemaestro market context Price below Trend Line 52 weeks +8.4% · Next-week setup positive 63.6% AFJK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aimei Health Technology Co Ltd

This article provides an overview of Aimei Health Technology Co Ltd (AFJK), including its current stock price, market cap, and P/E ratio. It notes that relevant revenue breakdown data by business segment and region has not been disclosed by the company yet. The page …

AFJK main company
Sharemaestro market context Price below Trend Line 52 weeks +8.4% · Next-week setup positive 63.6% AFJK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aimei Health Technology Co Ltd (AFJK) Financial Health: Profitability & Balance Sheet Analysis

This article provides an analysis of the financial health of Aimei Health Technology Co Ltd (AFJK), focusing on its profitability and balance sheet. It presents current stock performance data, including market capitalization and P/E ratio. The content also highlights available financial tools and resources …

AFJK main company
Sharemaestro market context Price below Trend Line 52 weeks +8.4% · Next-week setup positive 63.6% AFJK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aimei Health Technology Co Ltd (AFJK) Income Statement

This article presents the quarterly and annual income statements for Aimei Health Technology Co Ltd (AFJK), offering detailed financial insights into its operational efficiency and performance from FY2024Q1 to FY2026Q1. It breaks down various financial metrics including operating expenses, operating profit, non-operating interest income, …

AFJK main company
Sharemaestro market context Price below Trend Line 52 weeks +8.4% · Next-week setup positive 63.6% AFJK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aimei Health Technology Co Ltd (AFJK) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Aimei Health Technology Co Ltd (AFJK), covering its volatility, financial risk, and investment risk. It details various metrics such as maximum drawdown, daily returns, Sharpe ratio, and different types of volatility, along with liquidity indicators. The data …

AFJK main company
Sharemaestro market context Price below Trend Line 52 weeks +8.4% · Next-week setup positive 63.6% AFJK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AFJK|Aimei Health Technology Co Ltd|Price:11.760|Chg%:-0.080

This article provides a financial overview of Aimei Health Technology Co Ltd (AFJK), including its stock price, market cap, P/E ratio, and upcoming earnings date. It details the company's financial performance through income statements, balance sheets, and cash flow statements, offering both quarterly and …

AFJK main company
Sharemaestro market context Price below Trend Line 52 weeks +8.4% · Next-week setup positive 63.6% AFJK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context